Саркома Капоши

Список литературы

Основные статьи

Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med. 2000 Apr 6;342(14):1027-38.Полный текст  Аннотация

Gallafent JH, Buskin SE, De Turk PB, et al. Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy. J Clin Oncol. 2005 Feb 20;23(6):1253-60.Полный текст  Аннотация

Patel RM, Goldblum JR, Hsi ED. Immunohistochemical detection of human herpesvirus-8 latent nuclear antigen-1 is useful in the diagnosis of Kaposi sarcoma. Mod Pathol. 2004 Apr;17(4):456-60.Полный текст  Аннотация

Department of Health and Human Services panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. Jul 2019 [internet publication].Полный текст

Gbabe OF, Okwundu CI, Dedicoat M, et al. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults. Cochrane Database Syst Rev. 2014;(9):CD003256.Полный текст  Аннотация

Статьи, указанные как источники

1. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994 Dec 16;266(5192):1865-9. Аннотация

2. Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med. 2000 Apr 6;342(14):1027-38.Полный текст  Аннотация

3. Geddes M, Franceschi S, Barchielli A, et al. Kaposi's sarcoma in Italy before and after the AIDS epidemic. Br J Cancer. 1994 Feb;69(2):333-6. Аннотация

4. Guttman-Yassky E, Bar-Chana M, Yukelson A, et al. Epidemiology of classic Kaposi's sarcoma in the Israeli Jewish population between 1960 and 1998. Br J Cancer. 2003 Nov 3;89(9):1657-60.Полный текст  Аннотация

5. Mbulaiteye SM, Engels EA. Kaposi's sarcoma risk among transplant recipients in the United States (1993-2003). Int J Cancer. 2006 Dec 1;119(11):2685-91.Полный текст  Аннотация

6. Hosseini-Moghaddam SM, Soleimanirahbar A, Mazzulli T, et al. Post renal transplantation Kaposi's sarcoma: a review of its epidemiology, pathogenesis, diagnosis, clinical aspects, and therapy. Transpl Infect Dis. 2012 Aug;14(4):338-45. Аннотация

7. Cook-Mozaffari P, Newton R, Beral V, et al. The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. Br J Cancer. 1998 Dec;78(11):1521-8. Аннотация

8. Engels EA, Pfeiffer RM, Goedert JJ, et al; HIV/AIDS Cancer Match Study. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS. 2006 Aug 1;20(12):1645-54. Аннотация

9. American Cancer Society. Cancer Facts & Figures 2017 Special Section: Rare Cancers in Adults. 2017 [internet publication].Полный текст

10. Semango GP, Charles RM, Swai CI, et al. Prevalence and associated risk factors for Kaposi's sarcoma among HIV-positive patients in a referral hospital in Northern Tanzania: a retrospective hospital-based study. BMC Cancer. 2018 Dec 17;18(1):1258.Полный текст  Аннотация

11. Douglas JL, Gustin JK, Dezub BJ, et al. Kaposi's sarcoma: a model of both malignancy and chronic inflammation. Panminerva Medica. 2007 Sep;49(3):119-38. Аннотация

12. Pantanowitz L, Früh K, Marconi S, et al. Pathology of rituximab-induced Kaposi sarcoma flare. BMC Clin Pathol. 2008 Jul 23;8:7.Полный текст  Аннотация

13. Gallafent JH, Buskin SE, De Turk PB, et al. Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy. J Clin Oncol. 2005 Feb 20;23(6):1253-60.Полный текст  Аннотация

14. Sullivan RJ, Pantanowitz L, Casper C, et al. HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease. Clin Infect Dis. 2008 Nov 1;47(9):1209-15.Полный текст  Аннотация

15. Dezube BJ, Pantanowitz L, Aboulafia DM. Management of AIDS-related Kaposi sarcoma: advances in target discovery and treatment. AIDS Read. 2004 May;14(5):236-8. Аннотация

16. Di Lorenzo G, Konstantinopoulos PA, Pantanowitz L, et al. Management of AIDS-related Kaposi's sarcoma. Lancet Oncol. 2007 Feb;8(2):167-76. Аннотация

17. Panel on Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV. November 2019 [internet publication].Полный текст

18. Cannon MJ, Operskalski EA, Mosley JW, et al. Lack of evidence for human herpesvirus-8 transmission via blood transfusion in a historical US cohort. J Infect Dis. 2009 Jun 1;199(11):1592-8.Полный текст  Аннотация

19. Schennach H, Schönitzer D, Wachter H, et al. Blood donations and viruses. Lancet. 1997 May 3;349(9061):1327-8.Полный текст  Аннотация

20. Lodi S, Guiguet M, Costagliola D, et al. Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion. J Natl Cancer Inst. 2010 Jun 2;102(11):784-92.Полный текст  Аннотация

21. Dubrow R, Qin L, Lin H, et al. Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada. J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):382-390.Полный текст  Аннотация

22. Cianfrocca M, Lee S, Von Roenn J, et al. Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy. Cancer. 2010 Aug 15;116(16):3969-77.Полный текст  Аннотация

23. Cooley T, Henry D, Tonda M, et al. A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma. Oncologist. 2007 Jan;12(1):114-23.Полный текст  Аннотация

24. Radu O, Pantanowitz L. Kaposi sarcoma. Arch Pathol Lab Med. 2013 Feb;137(2):289-94.Полный текст  Аннотация

25. Cheuk W, Wong KO, Wong CS, et al. Immunostaining for human herpesvirus 8 latent nuclear antigen-1 helps distinguish Kaposi sarcoma from its mimickers. Am J Clin Pathol. 2004 Mar;121(3):335-42. Аннотация

26. Patel RM, Goldblum JR, Hsi ED. Immunohistochemical detection of human herpesvirus-8 latent nuclear antigen-1 is useful in the diagnosis of Kaposi sarcoma. Mod Pathol. 2004 Apr;17(4):456-60.Полный текст  Аннотация

27. Pitchenik AE, Fischl MA, Saldana MJ. Kaposi's sarcoma of the tracheobronchial tree. Clinical, bronchoscopic, and pathologic features. Chest. 1985 Jan;87(1):122-4. Аннотация

28. Zibrak JD, Silvestri RC, Costello P, et al. Bronchoscopic and radiologic features of Kaposi's sarcoma involving the respiratory system. Chest. 1986 Oct;90(4):476-9. Аннотация

29. Kodra A, Walczyszyn M, Grossman C, et al. Case report: pulmonary Kaposi sarcoma in a non-HIV patient. F1000Res. 2015 Oct 7;4:1013.Полный текст  Аннотация

30. Casper C, Krantz E, Taylor H, et al. Assessment of a combined testing strategy for detection of antibodies to human herpesvirus 8 (HHV-8) in persons with Kaposi's sarcoma, persons with asymptomatic HHV-8 infection, and persons at low risk for HHV-8 infection. J Clin Microbiol. 2002 Oct;40(10):3822-5.Полный текст  Аннотация

31. Caponetti G, Dezube BJ, Restrepo C, et al. Kaposi sarcoma of the musculoskeletal system: a review of 66 patients. Cancer. 2007 Mar 15;109(6):1040-52.Полный текст  Аннотация

32. Wang J, Stebbing J, Bower M. HIV-associated Kaposi sarcoma and gender. Gend Med. 2007 Sep;4(3):266-73. Аннотация

33. Morooka M, Ito K, Kubota K, et al. Whole-body 18F-fluorodeoxyglucose positron emission tomography/computed tomography images before and after chemotherapy for Kaposi sarcoma and highly active antiretrovirus therapy. Jpn J Radiol. 2010 Dec;28(10):759-62. Аннотация

34. Pantanowitz L, Dezube BJ, Pinkus GS, et al. Histological characterization of regression in acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Cutan Pathol. 2004 Jan;31(1):26-34. Аннотация

35. Purgina B, Rao UN, Miettinen M, et al. AIDS-related EBV-associated smooth muscle tumors: a review of 64 published cases. Patholog Res Int. 2011 Mar 10;2011:561548.Полный текст  Аннотация

36. Krown SE, Metroka C, Wernz JC. Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. J Clin Oncol. 1989 Sep;7(9):1201-7. Аннотация

37. Nasti G, Talamini R, Antinori A, et al. AIDS-related Kaposi's sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS clinical trial group staging system in the HAART era - the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naïve From Antiretrovirals. J Clin Oncol. 2003 Aug 1;21(15):2876-82. Аннотация

38. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod C, ed. Evaluation of chemotherapeutic agents. New York, NY: Columbia University Press; 1949:196.

39. Brambilla L, Boneschi V, Taglioni M, et al. Staging of classic Kaposi's sarcoma: a useful tool for therapeutic choices. Eur J Dermatol. 2003 Jan-Feb;13(1):83-6. Аннотация

40. Pantanowitz L, Dezube BJ. Advances in the pathobiology and treatment of Kaposi sarcoma. Curr Opin Oncol. 2004 Sep;16(5):443-9. Аннотация

41. Kutlubay Z, Küçüktaş M, Yardimci G, et al. Evaluation of effectiveness of cryotherapy on the treatment of cutaneous Kaposi's sarcoma. Dermatol Surg. 2013 Oct;39(10):1502-6. Аннотация

42. Caccialanza M, Marca S, Piccinno R, et al. Radiotherapy of classic and human immunodeficiency virus-related Kaposi's sarcoma: results in 1482 lesions. J Eur Acad Dermatol Venereol. 2008 Mar;22(3):297-302. Аннотация

43. Krown SE, Northfelt DW, Osoba D, et al. Use of liposomal anthracyclines in Kaposi's sarcoma. Semin Oncol. 2004 Dec;31(6 suppl 13):36-52. Аннотация

44. Gill PS, Wernz J, Scadden DT, et al. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. J Clin Oncol. 1996 Aug;14(8):2353-64. Аннотация

45. Raimundo KP, Asche CV. A review of the efficacy and outcomes studies of currently approved chemotherapy treatments for advanced AIDS-Kaposi's sarcoma. HIV AIDS Rev. 2011 Sep;10(3):56-60.

46. Dhillon T, Stebbing J, Bower M. Paclitaxel for AIDS-associated Kaposi's sarcoma. Expert Rev Anticancer Ther. 2005 Apr;5(2):215-9. Аннотация

47. Gill PS, Tulpule A, Espina BM, et al. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma. J Clin Oncol. 1999 Jun;17(6):1876-83. Аннотация

48. Nasti G, Errante D, Talamini R, et al. Vinorelbine is an effective and safe drug for AIDS-related Kaposi's sarcoma: results of a phase II study. J Clin Oncol. 2000 Apr;18(7):1550-7. Аннотация

49. Krueter A, Rasokat H, Klouche N, et al. Liposomal pegylated doxorubicin versus low-dose recombinant interferon alfa-2a in the treatment of advanced classic Kaposi's sarcoma: retrospective analysis of three German centers. Cancer Invest. 2005;23(8):653-9. Аннотация

50. Krown SE, Li P, Von Roenn JH, et al. Efficacy of low-dose interferon with antiretroviral therapy in Kaposi's sarcoma: a randomized phase II AIDS clinical trials group study. J Interferon Cytokine Res. 2002 Mar;22(3):295-303. Аннотация

51. Evans SR, Krown SE, Testa MA, et al. Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study. J Clin Oncol. 2002 Aug 1;20(15):3236-41. Аннотация

52. Strother RM, Gregory KM, Pastakia SD, et al. Retrospective analysis of the efficacy of gemcitabine for previously treated AIDS-associated Kaposi's sarcoma in western Kenya. Oncology. 2010;78(1):5-11.Полный текст  Аннотация

53. Brambilla L, Recalcati S, Tourlaki A. Vinorelbine therapy in classic Kaposi's sarcoma: a retrospective study of 20 patients. Eur J Dermatol. 2015 Nov-Dec;25(6):535-8. Аннотация

54. Tas F, Sen F, Keskin S, et al. Oral etoposide as first-line therapy in the treatment of patients with advanced classic Kaposi's sarcoma (CKS): a single-arm trial (oral etoposide in CKS). J Eur Acad Dermatol Venereol. 2013 Jun;27(6):789-92. Аннотация

55. Brambilla L, Labianca R, Ferrucci SM, et al. Treatment of classical Kaposi's sarcoma with gemcitabine. Dermatology. 2001;202(2):119-22. Аннотация

56. Tur E, Brenner S, Michalevicz R. Low dose recombinant interferon alfa treatment for classic Kaposi's sarcoma. Arch Dermatol. 1993 Oct;129(10):1297-300. Аннотация

57. Costa da Cunha CS, Lebbe C, Rybojad M, et al. Long-term follow-up of non-HIV Kaposi's sarcoma treated with low-dose recombinant interferon alfa-2b. Arch Dermatol. 1996 Mar;132(3):285-90. Аннотация

58. Department of Health and Human Services panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. Jul 2019 [internet publication].Полный текст

59. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach - second edition, 2016. Jun 2016 [internet publication].Полный текст

60. Bower M, Dalla Pria A, Coyle C, et al. Prospective stage-stratified approach to AIDS-related Kaposi's sarcoma. J Clin Oncol. 2014 Feb 10;32(5):409-14. Аннотация

61. Gbabe OF, Okwundu CI, Dedicoat M, et al. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults. Cochrane Database Syst Rev. 2014;(9):CD003256.Полный текст  Аннотация

62. Shepherd FA, Maher E, Cardella C, et al. Treatment of Kaposi's sarcoma after solid organ transplantation. J Clin Oncol. 1997 Jun;15(6):2371-7. Аннотация

63. Lebbé C, Euvrard S, Barrou B, et al. Sirolimus conversion for patients with posttransplant Kaposi's sarcoma. Am J Transplant. 2006 Sep;6(9):2164-8.Полный текст  Аннотация

64. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. Mar 2018 [internet publication].Полный текст

65. Bodsworth NJ, Bloch M, Bower M, et al; International Panretin Gel KS Study Group. Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma. Am J Clin Dermatol. 2001;2(2):77-87. Аннотация

66. Epstein JB. Treatment of oral Kaposi sarcoma with intralesional vinblastine. Cancer. 1993 Mar 1;71(5):1722-5. Аннотация

67. Stein ME, Spencer D, Ruff P, et al. Endemic African Kaposi sarcoma: clinical and therapeutic implications. 10-year experience in the Johannesburg Hospital (1980-1990). Oncology. 1994 Jan-Feb;51(1):63-9. Аннотация

68. Little RF, Wyvill KM, Pluda JM, et al. Activity of thalidomide in AIDS-related Kaposi's sarcoma. J Clin Oncol. 2000 Jul;18(13):2593-602. Аннотация

69. Dezube BJ, Von Roenn JH, Holden-Wiltse J, et al. Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team. J Clin Oncol. 1998 Apr;16(4):1444-9. Аннотация

70. Dezube BJ, Krown SE, Lee JY, et al. Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study. J Clin Oncol. 2006 Mar 20;24(9):1389-94.Полный текст  Аннотация

71. Koon HB, Bubley GJ, Pantanowitz L, et al. Imatinib-induced regression of AIDS-related Kaposi's sarcoma. J Clin Oncol. 2005 Feb 10;23(5):982-9.Полный текст  Аннотация

72. Uldrick TS, Wyvill KM, Kumar P, et al. Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy. J Clin Oncol. 2012 May 1;30(13):1476-83.Полный текст  Аннотация

73. Wang X, Bao Z, Zhang X, et al. Effectiveness and safety of PD-1/PD-L1 inhibitors in the treatment of solid tumors: a systematic review and meta-analysis. Oncotarget. 2017 May 31;8(35):59901-14.Полный текст  Аннотация

74. ClinicalTrials.gov. Phase II multicentric study of pembrolizumab in classic or endemic Kaposi's sarcoma (KAPKEY). Mar 2018 [internet publication].Полный текст

75. Krown SE, Roy D, Lee JY, et al. Rapamycin with antiretroviral therapy in AIDS-associated Kaposi sarcoma: an AIDS Malignancy Consortium study. J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):447-54.Полный текст  Аннотация

76. Polizzotto MN, Uldrick TS, Wyvill KM, et al. Pomalidomide for symptomatic Kaposi's sarcoma in people with and without HIV infection: a phase I/II study. J Clin Oncol. 2016 Dec;34(34):4125-31.Полный текст  Аннотация

77. ClinicalTrials.gov. Pomalidomide in combination with liposomal doxorubicin in people with advanced or refractory Kaposi sarcoma. Nov 2017 [internet publication].Полный текст

78. ClinicalTrials.gov. sEphB4-HSA in treating patients with Kaposi sarcoma. Mar 2018 [internet publication].Полный текст

79. Miles SA, Dezube BJ, Lee JY, et al; AIDS Malignancy Consortium. Antitumor activity of oral 9-cis-Retinoic acid in HIV-associated Kaposi's sarcoma. AIDS. 2002 Feb 15;16(3):421-9. Аннотация

80. Aboulafia DM, Norris D, Henry D, et al. 9-cis-retinoic acid capsules in the treatment of AIDS-related Kaposi sarcoma: results of a phase 2 multicenter clinical trial. Arch Dermatol. 2003 Feb;139(2):178-86. Аннотация

81. Little RF, Pluda JM, Wyvill KM, et al. Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma. Blood. 2006 Jun 15;107(12):4650-7.Полный текст  Аннотация

82. Little RF, Aleman K, Kumar P, et al. Phase 2 study of pegylated liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi sarcoma. Blood. 2007 Dec 15;110(13):4165-71.Полный текст  Аннотация

83. Gill PS, Lunardi-Ishkandar Y, Louie S, et al. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. N Engl J Med. 1996 Oct 24;335(17):1261-9.Полный текст  Аннотация

84. Gill PS, McLaughlin T, Espina BM, et al. Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma. J Natl Cancer Inst. 1997 Dec 3;89(23):1797-802. Аннотация

85. ClinicalTrials.gov. Nelfinavir mesylate in treating patients with Kaposi sarcoma. Apr 2018 [internet publication].Полный текст

86. Feller L, Masipa J, Wood N, et al. The prognostic significance of facial lymphoedema in HIV-seropositive subjects with Kaposi sarcoma. AIDS Res Ther. 2008 Jan 29;5:2.Полный текст  Аннотация

87. Pantanowitz L, Dezube BJ. AIDS-associated Kaposi sarcoma of the larynx. AIDS Read. 2006 Apr;16(4):194-5. Аннотация

Использование этого контента попадает под действие нашего заявления об отказе от ответственности